Last summer we announced a study being conducted at the University of Oklahoma to learn more about Raynaud's sufferers' experiences during pregnancy. The researchers wanted to determine if patients with Raynaud's phenomenon have a higher incidence of complications during pregnancy than non-sufferers. We've just received the results of the study, and while the sample size is
Kansas State University is recruiting Raynaud's sufferers to participate in a survey correlating lifestyle and nutrition to Raynaud's symptoms. Below is a background statement from the researcher who initiated the study, along with a link to the survey: Hello fellow Raynaud’s Association members! My name is Kourtney Foley and I currently attend Kansas State University. I have been
Botox® has shown promising results in treating Raynaud's, so we're glad to see the exploration of more clinical trials of Botox® for Raynaud's.
We have been contacted by a pharmaceutical company to help recruit patients for a clinical trial being conducted in patients with Raynaud’s phenomenon secondary to scleroderma/systemic sclerosis. The study medication is a topical cream that will be applied to the hand. Participation will require travel to a clinical site. The first site is in Encinitas,
The University of Oklahoma Health Science Center Department of Obstetrics and Gynecology is recruiting Raynaud's sufferers to participate in a survey regarding their experiences during pregnancy. The objective of the research is to provide information on the prevalence of pregnancy complications in patients with Raynaud’s phenomenon. To qualify, participants should meet the following criteria: Female
